Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	2,203	2,134	1,470	1,537	1,674	1,858	1,979	1,855	2,153	2,139	2,180
COGS	-4	-212	781	879	888	989	1,102	1,066	1,106	1,084	1,110
Gross profit	—	—	688	659	786	869	877	789	1,047	1,056	1,070
	1,927	2,067	491	520	576	681	801	690	792	793	785
	281	279	197	139	210	187	77	98	255	262	285
OPM %	12.8%	13.1%	13.4%	9%	12.6%	10.1%	3.9%	5.3%	11.9%	12.3%	13.1%
Depreciation	106	127	78	83	92	99	104	94	85	85	91
Interest	103	115	82	54	67	65	74	139	168	146	114
	117	98	862	107	100	89	123	69	67	2,873	123
Profit before tax	189	135	899	109	152	112	22	-65	70	2,905	203
Tax	28	15	8	-1	40	33	-159	-69	4	19	19
Tax %	14.9%	11.4%	0.9%	-1.3%	26.5%	29.9%	-737.7%	-107.2%	5.9%	0.7%	9.6%
	161	109	892	110	112	78	180	5	65	2,886	184
PAT margin %	7.3%	5.1%	60.7%	7.2%	6.7%	4.2%	9.1%	0.3%	3%	134.9%	8.4%
EPS (₹)	21.7	12.2	99.7	12.3	12.5	8.7	20.1	0.5	7.2	313.7	19.9
EPS adjusted (₹)	27	12.1	99.6	12.3	12.5	8.7	20.1	0.5	7.1	313.2	19.9
	18.4%	37%	2%	24.3%	112.3%	28.6%	0%	288.5%	34.7%	1.3%	25.1%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	60	89	90	90	90	90	90	90	92	92	92
Reserves	1,441	3,143	3,073	3,167	3,069	3,158	3,317	3,365	3,469	3,101	3,191
Minority interest	—	0	—	—	—	—	—	—	—	0	—
	327	1,417	604	809	852	879	1,245	1,349	1,594	1,156	1,148
	361	832	519	597	666	1,094	783	815	682	682	964
Total equity & liabilities	2,189	5,481	4,285	4,663	4,677	5,221	5,434	5,620	5,838	5,031	5,396
	317	1,124	498	497	535	577	604	584	545	756	785
CWIP	21	100	87	73	89	81	30	16	58	66	84
Investments	1,007	2,520	1,777	2,149	2,171	2,462	2,413	2,504	2,510	1,859	1,868
	844	1,738	1,924	1,945	1,882	2,101	2,387	2,516	2,726	2,351	2,659
Total assets	2,189	5,481	4,285	4,663	4,677	5,221	5,434	5,620	5,838	5,031	5,396

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2024 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Pharmaceutical business	2,153.26	237.55	—	2,276.66
Bio-pharmaceutical business	0	0	—	0

SegmentFigure

Bio-pharmaceutical business · revenue

₹ crore by fiscal year

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	83	412	66	40	138	283	-283	242	-36	421	278
	-1,064	-344	447	-166	63	-276	19	-183	-61	-138	-69
	1,571	-67	-707	123	-204	-49	251	11	108	-370	-199
Net cash flow	590	0	-194	-3	-3	-42	-13	70	11	-86	10
Free cash flow	—	—	—	—	—	194	-351	161	-103	255	109
CFO / Operating profit %	29.5%	147.3%	33.3%	28.8%	65.5%	151%	-368.9%	245.5%	-14%	160.6%	97.5%